The U.S. alleged that the China-based company spent around 10 years distributing chemicals used to make the lethal drug.

AstraZeneca's China president Leon Wang, who was detained last month by Chinese authorities, is in touch with a lawyer but ...

A watchdog letter is urging U.S. state leaders to divest public funds from China, citing rising risks of geopolitical ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...

Michael Burry's Scion Asset Management ramped up its bets on three Chinese tech giants but also hedged its positions.

Pony AI is inching closer to its initial public offering in the U.S., but as it does so, it continues to drop its minimum ...

AstraZeneca Plc isn’t the only health-care company facing compliance questions in China as concern continued to swirl about a ...

Nigeria has inked a $1.2 billion deal with a Chinese firm to revitalize a gas processing facility, a move that officials say ...

The FBI and CISA previously said they were investigating breaches by a China-backed hacking group inside several ...

WASHINGTON (Reuters) -China-linked hackers have intercepted surveillance data intended for American law enforcement agencies ...

China's Taiwan Affairs Office said on Wednesday that a U.S. order to Taiwan Semiconductor Manufacturing Co to halt shipments ...